Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Three-drug therapy shown effective against AIDS

June 24, 1997

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

June 18, 1997

FDA advisory on AIDS drugs

June 17, 1997

Second-generation NNRTI under development by Hoechst/Bayer

June 16, 1997

Paracelsian cancels launch of AndroVir

June 12, 1997

Carbovir not associated with mitochondrial toxicity in intact cells

June 12, 1997

Nevirapine for prophylaxis of HIV infection

June 11, 1997

Introduction of Rescriptor in late June

June 10, 1997

Anti-HIV vaccines reported by Duke University

June 6, 1997

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...